Home » Archive

News

Marketwire, News, Syndication »

Genelux Corporation Announces Phase I Data Presentation at 2012 ASCO Annual Meeting of GL-ONC1, Its Oncolytic Virus Lead Product Candidate

Posted by Mary Canady May 30th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 30, 2012) – Genelux Corporation, a privately held, clinical-stage biopharmaceutical company focused on development and commercialization of best-in-class, vaccinia-virus-based oncolytic viral therapies and companion …

More...

Marketwire, News, Syndication »

Ardea Biosciences Earns Milestone From Bayer HealthCare

Posted by Mary Canady May 30th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 30, 2012) – Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced that it has earned a $7.5 million milestone from Bayer HealthCare (Bayer) under the terms of their April 2009 global license agreement to develop and…

More...

Marketwire, News, Syndication »

Cytori Obtains Celution(R) Approval in Russia; To Launch Product Line for Plastic Surgery and Select Soft Tissue Therapies

Posted by Mary Canady May 30th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 30, 2012) – Cytori Therapeutics (NASDAQ: CYTX) has obtained approval to sell the Celution® 800 System in Russia for various medical uses. These clinical uses are based on those in the current European CE Mark, and i…

More...

News, Syndication, Xconomy »

Basic Biology: The Complex Core of Drug Discovery

Posted by sandiegobiotech May 30th, 2012 .
No Comments

The hardest task in major league sports is hitting a baseball. Those who can successfully do this even three out of every ten times over the course of a career are likely to find themselves enshrined…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data

Posted by sandiegobiotech May 29th, 2012 .
No Comments

Vertex Pharmaceuticals saw its stock rocket on news earlier this month that its two-drug combo treatment for cystic fibrosis showed a strong benefit in a clinical trial, but the stock is coming back…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

Safety Analyses Lead Sangart to Move Ahead with ‘Oxygen Therapeutic’

Posted by sandiegobiotech May 28th, 2012 .
No Comments

Encouraging results in a second mid-stage trial of an oxygen-carrying compound has prompted San Diego’s Sangart to draw on an additional $50 million from Leucadia National (NYSE: LUK), a diversified…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Xconomist of the Week: Evan Snyder—Stem Cell Reality Check

Posted by sandiegobiotech May 25th, 2012 .
No Comments

San Diego Xconomist Evan Snyder has been called a “stem cell revolutionary” and is regarded as a father in the field of stem cell research. When we talked in his office at San Diego’s Sanford-Burnham…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Xconomist of the Week: Evan Snyder—Stem Cell Reality Check

Posted by sandiegobiotech May 25th, 2012 .
No Comments

San Diego Xconomist Evan Snyder has been called a “stem cell revolutionary” and is regarded as a father in the field of stem cell research. When we talked in his office at San Diego’s Sanford-Burnham…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

Posted by Mary Canady May 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 25, 2012) – La Jolla Pharmaceutical Company (OTCQB: LJPC) (PINKSHEETS: LJPC) (the “Company” and “La Jolla”) held its 2012 Annual Meeting of Stockholders on May 22. All matters submitted to a vote of the stockholders …

More...

Marketwire, News, Syndication »

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

Posted by Mary Canady May 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 25, 2012) – La Jolla Pharmaceutical Company (OTCQB: LJPC) (PINKSHEETS: LJPC) (the “Company” and “La Jolla”) held its 2012 Annual Meeting of Stockholders on May 22. All matters submitted to a vote of the stockholders …

More...